Acasti Pharma Inc (ACST.O)
ACST.O on Consolidated Issue listed on NASDAQ Capital Market
2.99USD
1 Jul 2013
2.99USD
1 Jul 2013
Price Change (% chg)
$0.16 (+5.65%)
$0.16 (+5.65%)
Prev Close
$2.83
$2.83
Open
$2.85
$2.85
Day's High
$2.99
$2.99
Day's Low
$2.78
$2.78
Volume
22,900
22,900
Avg. Vol
22,445
22,445
52-wk High
$3.99
$3.99
52-wk Low
$1.61
$1.61
ACST.O
About
Acasti Pharma Inc. (Acasti) is engaged in developing a product portfolio of long-chain omega-3 phospholipids. Acasti is a majority owned subsidiary of Neptune Technologies and Bioressources Inc. (Neptune). The Company has one operating segment: the development and commercialization of pharmaceutical applications of its licensed... (more)
No analyst recommendations are available for ACST.O.
Overall
| Beta: | -- |
| Market Cap (Mil.): | $216.64 |
| Shares Outstanding (Mil.): | 73.19 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ACST.O | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 32.92 | 33.02 |
| EPS (TTM): | -0.09 | -- | -- |
| ROI: | -52.84 | 19.76 | 19.07 |
| ROE: | -52.84 | 20.57 | 20.00 |
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
